Data set containing historical information for placebo arm of a phase II proof-of-concept trial for the treatment of ulcerative colitis. The primary outcome is remission at week 8 (binary).
Data set containing historical information for placebo arm of a phase II proof-of-concept trial for the treatment of ulcerative colitis. The primary outcome is remission at week 8 (binary).